Clinical Trial Details
EORTC-16032-18031
Back to Clinical Trials Database
Randomized, open phase II study of immunization with the recombinant MAGE-3 protein combined with adjuvant AS02B or AS15 in patients with unresectable and progressive metastatic cutaneous melanoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 12-May-2004 Date Step1 close: 24-Jan-2007 Date Step2 close: 24-Jan-2007 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 68 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00086866 |
| NCT number | NCT00086866 |
| EudraCT | 2004-001937-40 |
